Saeed Vaheb
Isfahan University of Medical Sciences
EpidemiologyInternal medicineVirologyRetrospective cohort studyBalance (ability)Mortality ratePrevalencePhysical therapySensory lossExacerbationSpectrum disorderCoronavirusPneumoniaBetacoronavirusMigraineOcrelizumabDepression (differential diagnoses)DiseaseComorbidityMEDLINEFear of fallingMultiple sclerosisExpanded Disability Status ScaleFalling (sensation)Neuromyelitis opticaCINAHLPopulationCoronavirus InfectionsSeverity of illness2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)X ray computedIncreased riskFavorable outcomeAge and sexAnxietyMedicinePandemic
7Publications
5H-index
35Citations
Publications 7
Newest
OBJECTIVE We systematically reviewed the literature on COVID-19 in patients with multiple sclerosis (MS). METHODS We searched PubMed, Scopus, EMBASE, CINAHL, Web of Science, Google Scholar, and World Health Organization database from December 1, 2019, to December 18, 2020. Three conference abstract databases were also searched. We included any types of studies that reported characteristics of patients with MS with COVID-19. RESULTS From an initial 2,679 publications and 3,138 conference abstract...
Source
#1Mahdi Barzegar (IUMS: Isfahan University of Medical Sciences)H-Index: 8
#2Saeed Vaheb (IUMS: Isfahan University of Medical Sciences)H-Index: 5
Last. Vahid Shaygannejad (IUMS: Isfahan University of Medical Sciences)H-Index: 25
view all 6 authors...
Abstract The effect of coronavirus disease (COVID-19) on the risk of relapse in multiple sclerosis (MS) have been unknown. In this retrospective study of 41 relapsing-remitting MS patients, number of relapses in pre-defined at risk-period (ARP) was compared with the previous two years. During the previous two years, a total of 32 attacks was reported, which 5 (15.6%) were during the at-risk period. After adjusting for age and sex, there was an increased risk of attack during ARP compared to the ...
Source
#1Mahdi Barzegar (IUMS: Isfahan University of Medical Sciences)H-Index: 8
#2Omid Mirmosayyeb (IUMS: Isfahan University of Medical Sciences)H-Index: 12
Last. Nasrin Asgari (University of Southern Denmark)H-Index: 26
view all 6 authors...
Abstract Background Comorbidity may influence clinical aspects of neuromyelitis optica spectrum disorder (NMOSD). We estimated the prevalence of comorbidities to assess their association with outcomes. Methods This retrospective study assessed records of NMOSD patients from 2008 to 2019, categorizing comorbidities into three groups: somatic, psychiatric and autoimmune. Severity of disease was evaluated by the Expanded Disability Status Scale, progression index (PI) and annualized relapse rate. T...
Source
#1Mahdi Barzegar (IUMS: Isfahan University of Medical Sciences)H-Index: 8
#2Dena Sadeghi Bahmani (Kermanshah University of Medical Sciences)H-Index: 15
Last. Serge Brand (University of Basel)H-Index: 62
view all 11 authors...
Background: Neuromyelitis optica spectrum disorder (NMOSD) is a chronic inflammatory and autoimmune disorder that is associated with impaired vision, sensory loss, pain, fatigue, and spasms in the upper and lower limbs. Typically, persons with this disorder are also at higher risks of falls. Given this, the aims of the study were to compare the prevalence rates of falling for NMOSD cases and healthy controls (HCs), and to predict falling in the former group based on sociodemographic, psychologic...
Source
#1Omid Mirmosayyeb (IUMS: Isfahan University of Medical Sciences)H-Index: 12
#2Saeed Vaheb (IUMS: Isfahan University of Medical Sciences)H-Index: 5
Last. Mahsa Ghajarzadeh (Tehran University of Medical Sciences)H-Index: 17
view all 6 authors...
Source
#1Mahdi Barzegar (IUMS: Isfahan University of Medical Sciences)H-Index: 8
#2Omid Mirmosayyeb (IUMS: Isfahan University of Medical Sciences)H-Index: 12
Last. Reza Vosoughi (St. Michael's Hospital)H-Index: 2
view all 7 authors...
Source
#1Mahsa Ghajarzadeh (Tehran University of Medical Sciences)H-Index: 17
#2Omid Mirmosayyeb (IUMS: Isfahan University of Medical Sciences)H-Index: 12
Last. Amir-Hadi Maghzi (Brigham and Women's Hospital)H-Index: 20
view all 7 authors...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.